← Open Payments lookup

KATHERINE FLYNN: Open Payments

NPI 1639654171 · BROOKHAVEN, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$679 in 31 payments from 11 companies in 2025. Trend: 2023 $238 · 2024 $347 · 2025 $679

Food & beverage: $679
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.8$193
ABBVIE INC.5$105
HARMONY BIOSCIENCES LLC3$97
Lundbeck LLC3$60
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$56
Janssen Pharmaceuticals, Inc2$38
Otsuka America Pharmaceutical, Inc.2$36
Supernus Pharmaceuticals, Inc.2$29
Neurocrine BioSciences, Inc.1$28
Tris Pharma Inc1$20

Products named: FANAPT, VRAYLAR, WAKIX, REXULTI, CAPLYTA, SPRAVATO, Qelbree, INGREZZA.

Industry payments across MS — which companies pay providers there.